bioRxivCancer Biology
Characterization of alternative splicing in high-risk Wilms tumors
Y. Trink, A. Urbach, B. Dekel, P. Hohenstein, J. Goldberger, T. Kalisky
Abstract
The significant heterogeneity of Wilms tumors between different patients is thought to arise from genetic and epigenetic distortions that occur during various stages of fetal kidney development in a way that is poorly understood. To address this, we characterized the heterogeneity of alternative mRNA splicing in Wilms tumors using a publicly available RNAseq dataset of high-risk Wilms tumors and normal kidney samples. Through Pareto task inference and cell deconvolution, we found that the tumors and normal kidney samples are organized according to progressive stages of kidney development within a triangle-shaped region in latent space, whose vertices, or "archetypes," resemble the cap mesenchyme, the nephrogenic stroma, and epithelial tubular structures of the fetal kidney. We identified a set of genes that are alternatively spliced between tumors located in different regions of latent space and found that many of these genes are associated with the Epithelial to Mesenchymal Transition (EMT) and muscle development. Using motif enrichment analysis, we identified putative splicing regulators, some of which are associated with kidney development. Our findings provide new insights into the etiology of Wilms tumors and suggest that specific splicing mechanisms in early stages of development may contribute to tumor development in different patients.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization of splice isoform switching during human kidney development
Yishay Wineberg, Itamar Kanter, … Tomer Kalisky C·bioRxiv·Oct 24, 2019
- The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor
D. Legge, L. Ling, … K. W. Brown·bioRxiv·Nov 2, 2020
- Characterization of the continuous transcriptional heterogeneity in Wilms tumors using unsupervised machine learning
Y. Trink, A. Urbach, … T. Kalisky·bioRxiv·Jun 6, 2022
- Podocyte lineage marker expression is preserved across Wilms tumor subtypes and enhanced in tumors harboring the SIX1/2 p.Q177R mutation
M. J. Stevenson, S. K. Phanor, … L. L. O'Brien·bioRxiv·Nov 2, 2022
- Single-cell RNA sequencing reveals mRNA splice isoform switching during kidney development
Yishay Wineberg, Tali Hana Bar-Lev, … Tomer Kalisky C·Journal of the American Society of NephrologyPeer-reviewed·Jul 10, 2020
- Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early stem cell origin
B. Royer-Pokora, W. Wruck, M. Beier·bioRxiv·Jun 10, 2022